BEIJING - Early on in the pandemic, mRNA Covid-19 vaccines produced by Pfizer-BioNTech and Moderna were widely shown to be more effective than Chinese-made shots, but Beijing made the decision not to import these foreign vaccines.
China instead bet that local vaccine makers would be able to catch up and develop more effective shots, a decision that experts say was motivated by vaccine nationalism and national security concerns.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
